You have 9 free searches left this month | for more free features.

carcinoid

Showing 1 - 25 of 467

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoid Syndrome, Carcinoid, Carcinoid Tumor Trial in Newport Beach, Lexington, Stony Brook (Randomized: 40 mg Paltusotine,

Recruiting
  • Carcinoid Syndrome
  • +8 more
  • Randomized: 40 mg Paltusotine
  • Randomized: 80 mg Paltusotine
  • Newport Beach, California
  • +5 more
Jan 3, 2023

Carcinoid Tumor Trial in Boston (Ziv-aflibercept)

Active, not recruiting
  • Carcinoid Tumor
  • Boston, Massachusetts
  • +2 more
Oct 14, 2022

Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

Completed
  • Neuroendocrine Tumors
  • +3 more
  • Amino Acid Based Medical Food/Drink
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 2, 2022

Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)

Active, not recruiting
  • Carcinoid Tumor
  • Pancreatic Neuroendocrine Tumor
  • Boston, Massachusetts
  • +1 more
Jul 15, 2022

Fibrosis in Chronic and Delayed Myocardial Infarction

Recruiting
  • Aortic Stenosis
  • +2 more
  • 68Ga-FAPI and 18F-AlF-FAPI PET-MR
  • Edinburgh, Scotland, United Kingdom
    University of Edinburgh
Mar 1, 2023

Tricuspid Regurgitation, Tricuspid Valve Disease, Carcinoid Syndrome Trial in London (Transcatheter Tricuspid Valved Stent

Not yet recruiting
  • Tricuspid Regurgitation
  • +3 more
  • Transcatheter Tricuspid Valved Stent Graft
  • London, England, United Kingdom
    Barts Health NHS Trust
Apr 19, 2022

Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,

Active, not recruiting
  • Carcinoid Tumor
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Buffalo, New York
  • +1 more
Nov 8, 2022

Carcinoid Tumors Trial in Boston (Ramucirumab, Somatostatin Analog)

Active, not recruiting
  • Carcinoid Tumors
  • Boston, Massachusetts
  • +1 more
Apr 14, 2022

Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

Recruiting
  • Advanced Lung Carcinoid Tumor
  • +11 more
  • Boston, Massachusetts
  • +1 more
Jul 19, 2022

Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide

Withdrawn
  • Neuroendocrine Tumors
  • +2 more
  • Telotristat ethyl
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospital and Clinics
Feb 9, 2022

Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

Not yet recruiting
  • Carcinoid Tumor Lung
  • +2 more
  • 212-Lead Pentixather
  • 203-Lead Pentixather SPECT/CT
  • Iowa City, Iowa
    The University of Iowa Theranostics Center
Sep 23, 2022

Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +6 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Aug 19, 2022

Neuroendocrine Tumors Trial (Telotristat Ethyl Oral Tablet)

Withdrawn
  • Neuroendocrine Tumors
  • Telotristat Ethyl Oral Tablet
  • (no location specified)
Dec 3, 2021

Small Bowel Cancer, Small Bowel Carcinoid Tumor, Quality of Life Trial in Lorenskog (Surgery with extended (D3) mesenterectomy

Recruiting
  • Small Bowel Cancer
  • +4 more
  • Surgery with extended (D3) mesenterectomy for small bowel tumors
  • Lorenskog, Norway
    Akershus University Hospital
Jan 3, 2023

Genetics of Appendix Cancer Study

Recruiting
  • Appendix Cancer
  • +14 more
  • Genetic profiling
  • Retrospective tissue procurement
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Feb 8, 2023

Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

Recruiting
  • Locally Advanced Neuroendocrine Neoplasm
  • Metastatic Neuroendocrine Neoplasm
  • Placebo Administration
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Advanced Neuroendocrine Tumor, Carcinoid Syndrome Trial (Retifanlimab, Telotristat Ethyl)

Withdrawn
  • Advanced Neuroendocrine Neoplasm
  • Carcinoid Syndrome
  • Retifanlimab
  • Telotristat Ethyl
  • (no location specified)
Sep 23, 2021

68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

Recruiting
  • Neuroendocrine Tumor Carcinoid
  • +2 more
    • Milan, Italy
      IRCCS Istituto Europeo di Oncologia S.r.l.
    Jul 8, 2022

    Carcinoid Syndrome Trial in Research Triangle Park (Xermelo)

    Completed
    • Carcinoid Syndrome
    • Research Triangle Park, North Carolina
      RTI-HS
    Jan 18, 2022

    Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 Trial in Houston (Dual-Energy Computed Tomography)

    Recruiting
    • Carcinoid Syndrome
    • +3 more
    • Dual-Energy Computed Tomography
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 28, 2021

    Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +18 more
    • Clinical Encounter
    • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Jul 24, 2023